Impacts of the international economic sanctions on Iranian patients with epilepsy

Epilepsy and Behavior

Volumn 95, Issue , 2019, Pages 166-168

  Asadi Pooya, Ali A ^a,b   Azizimalamiri, Reza ^c   Badv, Reza Shervin ^d   Yarali, Bahram ^d   Asadollahi, Marjan ^e   Homayoun, Maryam ^a   Sharifi, Samira ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug; Epilepsy; Iran; Sanctions

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; LEVETIRACETAM; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE; ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE CONTROL; DISEASE EXACERBATION; ECONOMIC ASPECT; ECONOMIC SANCTION; EPILEPSY; FEMALE; HEALTH CARE ACCESS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; SEIZURE; INFANT; MIDDLE AGED; POLITICS; PRESCHOOL CHILD; SOCIAL PROBLEM; VULNERABLE POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; POLITICS; SOCIAL PROBLEMS; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 85064981740     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2019.04.011     Document Type: Article

References (11)

1. Fiest, K.M., Sauro, K.M., Wiebe, S., Patten, S.B., Kwon, C.S., Dykeman, J., et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88 (2017), 296–303.
2. Asadi-Pooya, A.A., Emami, M., Ashjazadeh, N., Nikseresht, A., Shariat, A., Petramfar, P., et al. Reasons for uncontrolled seizures in adults; the impact of pseudointractability. Seizure 22 (2013), 271–274.
3. Asadi-Pooya, A.A., Tavana, B., Tavana, B., Emami, M., Drug adherence of patients with epilepsy in Iran: the effects of the international economic sanctions. Acta Neurol Belg 116 (2016), 151–155.
4. https://en.wikipedia.org/wiki/Iran_nuclear_deal_framework/. (Accessed 1 February 2019)
5. http://www.irna.ir/fa/News/81114320/. (Accessed 3 April 2019)
6. http://www.iran-newspaper.com/?nid=6818&pid=11&type=0/. (Accessed 3 April 2019)
7. Heidari, R., Akbariqomi, M., Tavoosidana, G., Medical legacy of sanctions in Iran. Nature, 552, 2017, 175.
8. Aloosh, M., How economic sanctions compromise cancer care in Iran. Lancet Oncol, 19, 2018, e334.
9. Cheraghali, A.M., Impacts of international sanctions on Iranian pharmaceutical market. Daru, 21, 2013, 64.
10. Setayesh, S., Mackey, T.K., Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Glob Health, 12, 2016, 31.
11. Stone, R., Renewed sanctions strangle science in Iran. Science, 361, 2018, 961.